Basic Information
Basic information for LINC00917-217-32aa
Peptide Name LINC00917-217-32aa
Genome Position chr16:86332959-86332975,86333829-86333907[-]
Species Human
Peptide Sequence METCAPGCEHFKGCHTGHTLRCLDSFDERAKP
Peptide Length 32
Unique No (LINC00917-201-32aa,LINC00917-204-32aa,LINC00917-206-32aa,LINC00917-207-32aa,LINC00917-209-32aa,LINC00917-210-32aa,LINC00917-211-32aa,LINC00917-213-32aa)
Grand Average of Hydropathicity -0.7031
Relative Molecular Mass 4136.64
Experimental Evidences no
lncRNA ID/Name ENSG00000168367;LINC00917
Transcript ID/Name ENST00000670118;LINC00917-217
Transcript Length 2513
Coding Ability 0.3645
DNA Sequence Corresponding to Peptide ATGGAGACCTGTGCACCTGGTTGTGAGCATTTTAAAGGGTGTCACACAGGGCATACCCTTCGGTGCCTGGATTCCTTTGATGAAAGGGCAAAGCCT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :